Chamada Retro Biosciences, the biotechnology startup sells the idea of increasing the “healthy human lifespan”. Based in San Francisco, the company works with the concept of cellular reprogramming. Now, with almost a billion reais more in cash and with the hands of influential investors behind it, Retro can transform human relationships with their own lives.
ADVERTISING
To get a sense of the novelty of the biohacking proposal, strong names in global technology have already invested money and excitement into the startup. In addition to Sam Altman, Lerry Page and Sergey Brin, founders of Google, also invest in biotechnology.
Expert warns of “magic discourse” in the proposal to increase human life
the doctoral candidate in Scientific and Technological Policy at Unicamp, Juliano Sanches, says that the arrival of the powerful in this field must be viewed with caution, and that people should not have a mystical view of technology: “There is a magical discourse, in the sense of that a powder or technology will bring us the long-awaited longevity. It is just the fetish of the commodity, which is performed within the scope of longevity.”
There are still no concrete results on what the technology proposes, but there are already a series of companies focused on biohacking, he mentions names that could stand out in the scenario, such as Unity Biotechnology, which has investment from billionaire Jeff Bezos, and other startups such as BioViva, Agez Therapeutics, Longevity Fund among others.
ADVERTISING
For now, there is no scientific evidence on methods involving biohacking to postpone aging and offer more years of life to humans.
@curtonews A #OpenAI became famous after the 'boom' of #ChatGPT. The platform's CEO's new bet is on #biohacking 🧬 #newsversobycurto ♬ original sound – Curto News
